Form 8-K12G3 - Notification of securities of successor issuers deemed to registered [Section 12]:
SEC Accession No. 0000950162-12-000004
Filing Date
2012-01-03
Accepted
2012-01-03 10:39:10
Documents
8
Period of Report
2011-12-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 XOMA FORM 8-K form8k.htm 8-K12G3 46175
2 CERTIFICATE OF INCORPORATION OF XOMA CORPORATION ex3_1.htm EX-3.1 65963
3 BY-LAWS OF XOMA CORPORATION ex3_2.htm EX-3.2 133937
4 FORM OF STOCK CERTIFICATE ex4_1.htm EX-4.1 1974
5 AMENDMENT NO. 2 TO THE RIGHTS AGREEMENT ex4_2.htm EX-4.2 48508
6 PRESS RELEASE ex99_1.htm EX-99.1 15773
7 xomastockcertpart1.jpg GRAPHIC 50779
8 xomastockcertpart2.jpg GRAPHIC 61169
  Complete submission text file 0000950162-12-000004.txt   468218
Mailing Address XOMA CORP /DE/ 2910 SEVENTH ST BERKLEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA LTD /DE/ (Filer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K12G3 | Act: 34 | File No.: 000-14710 | Film No.: 12500458
SIC: 2834 Pharmaceutical Preparations